Corporate Banner
Satellite Banner
Technology Networks Header
Saturday, December 20, 2014
 
Register | Sign in
Home Page>Products
  Product News
Bio-Rad’s Newest NGC™ Chromatography Systems Automate Workflow
Wednesday, November 05, 2014
The automation capabilities are ideal for advanced purification applications such as method optimization and multi-step and tandem protein purification.

Innova Introduces Lightning-Link Rapid Bioconjugation Kits
Tuesday, November 04, 2014
New kits enable customers to conjugate primary antibodies in 20 minutes.

A World First In Diagnostics
Tuesday, November 04, 2014
Device gives real-time intra-surgical molecular diagnosis from inside the body.

Nanolive, The Future Of Living Cell Microscopy
Monday, November 03, 2014
Nanolive SA has developed a revolutionary microscope which, for the very first time, allows the exploration of a living cell in 3D without damaging it.

New Precision Balances: Reliable, Compliant and Intuitive
Monday, November 03, 2014
METTLER TOLEDO's Excellence XPE precision balances make daily weighing tasks fast, easy and error-free.

Bio-Rad Introduces System to Automate Operation of Real-Time PCR Instruments
Monday, November 03, 2014
The CFX Automation System II automates the operation of up to two CFX Real-Time PCR Detection Systems.

Improved Method for Protein Quality Control
Friday, October 31, 2014
Separation of intact monoclonal antibody sialylation isoforms by pH gradient ion-exchange chromatography.

New Biotage® SNAP ULTRA C18 Cartridges
Friday, October 31, 2014
High performance reversed phase flash purification cartridges and samplets.

Agilent Introduces Powerful Enhancements to Leading Life Science Software
Friday, October 31, 2014
New GeneSpring platform enables faster discovery of complex relationships across multi-omic data.

<< 8 9 10 11 12 13 14 >>
Showing Results 101 - 110 of 10725
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
SELECTBIO Market Reports
LabTube - Videos for the Scientific Community
eposters - The Online Journal of Scientific Posters
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn